Surufatinib in G3 Neuroendocrine Tumors

Clinical trial NCT05973968 · UNKNOWN

Trial details

NCT number: NCT05973968
Sponsor: Qilu Hospital of Shandong University
Status: UNKNOWN
Study type: OBSERVATIONAL

Neuroendocrine Tumor Grade 3

Start date: 2023-08-01
Primary completion: 2024-06-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.